Anxiety Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Currently taking anxiolytics 2. Have moderate trait anxiety as defined by previously described State-Trait Inventory for Cognitive and Somatic Anxiety (STICSA) trait anxiety threshold scores
Exclusion criteria
Exclusion criteria: 1. Do not meet the criteria for moderate trait anxiety 2. Not actively taking anxiolytic medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| State Anxiety is measured using the State Trait Inventory for Cognitive and Somatic Anxiety at baseline and post-intervention (after 12, 24, or 36 minutes) | — |
Secondary
| Measure | Time frame |
|---|---|
| Affect measured using the Positive and Negative Affect Scale at baseline and post-intervention (after 12, 24, or 36 minutes) | — |
Countries
Australia, Brazil, Canada, Chile, Djibouti, England, Ireland, Israel, Italy, Malaysia, Mexico, Netherlands, Northern Ireland, Poland, Portugal, Romania, Scotland, South Africa, Spain, United Kingdom, United States of America, Wales